Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.

Emilien DelmontAlexandre BrodovitchLudivine KoutonThibaut AllouStéphane BeltranMarion BrissetJean Philippe CamdessanchéCécile CauquilJonathan CirionThierry DubardAndoni Echaniz-LagunaAude-Marie GrapperonJoëlle JauffretRaul Juntas-MoralesLaurent Daniel KremerThierry KuntzerCéline LabeyrieLucas LanfrancoThierry MaisonobeNicolas MavroudakisSylvie Mecharles-DarrigolGuillaume NicolasJean-Baptiste NouryMaud PerieYusuf A RajaballyGauthier RemicheViolaine RouaudCéline TardEmmanuelle Salort-CampanaAnnie VerschuerenKarine VialaAdrien WangShahram AttarianJosé Boucraut

Published in: Journal of neurology (2020)

Although rare, anti-paranodal antibodies are clinically valuable, because they are associated with specific phenotypes and therapeutic response.

Keyphrases

lymph node
risk factors
combination therapy
replacement therapy
smoking cessation